Project Grant R41DA064482
Award Date 7/1/26
Completion Date 6/30/27
Dollars Obligated $301K
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
- Federal Project Grant Award Summary Funding Agency: National Institute on Drug Abuse (NIDA) Federal Grant Program: Drug Use and Addiction Research Programs (CFDA 93.279) Award Amount: $398,580 Award Date: June 15, 2026 Project Completion: May 31, 2027 Awardee: Doro Mind Inc. Doro Mind Inc. will develop a digital platform designed to address adverse effects resulting from non-disordered drug use in individuals with serious mental illness (SMI). The platform will incorporate two primary...
- Federal Grant Award Summary Princeton University received a $164,000 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded August 15, 2025, with completion targeted for July 31, 2027. The award supports development of a Chemical Artificial Intelligence (AI) and Data Science Platform designed to identify and discover novel psychoactive substances (NPS). The project will deliver three primary products: (1) a...
- Federal Grant Award Summary Biomotivate LLC received a $613,744 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate the PEACE Platform (Personalized Evocative Audiovisual Content for Everyone), a precision medicine tool designed to support individuals with opioid use disorders (OUDs). The platform leverages generative artificial intelligence, machine learning algorithms, and physiological data...
- Federal Project Grant Summary Biosymetrics Inc. received $846,626 in federal funding from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) to develop an artificial intelligence-driven platform for therapeutic discovery targeting alcohol use disorder (AUD). The project, initiated August 1, 2025 and concluding July 31, 2026, leverages the company's commercially-deployed AI-based zebrafish behavioral screening platform, combined with...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $611,254 to The Marine Biological Laboratory (MBL) on August 1, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and deliver an advanced in-person research training course titled "Brains, Minds and Machine." The course, conducted at MBL's facilities in Woods Hole, Massachusetts, through July 31, 2028, addresses fundamental questions about how the brain produces...
- Federal Grant Award Summary Addinex Technologies, Inc. received a $613,056 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop an enhanced medication adherence and monitoring system for decentralized clinical trials in substance use disorder (SUD) treatment. The award, effective September 1, 2025 through August 31, 2026, funds the adaptation of Addinex's existing medication management platform to enable...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded McLean Hospital a $451,000 Project Grant on May 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop a biometrics-based platform for predicting opioid relapse. The primary deliverable is the development of machine learning (ML) algorithms that integrate physiological, behavioral, and subjective mood state data from wearable biosensors to identify real-time indicators of opioid...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded $314,109 to Behavior Change Hub LLC on June 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop the Addiction Application Gradebook, a web-based platform for evaluating and assessing smartphone and web applications targeting substance use disorder (SUD). This Phase One Small Business Technology Transfer (STTR) project will establish foundational research and development across three key...
- Federal Grant Award Summary Rescue Biomedical, LLC received a $799,430 Phase I Small Business Innovation Research (SBIR) grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and commercialize the Automatic Detection Device (AD2), a wearable overdose detection module. The project, which commenced August 1, 2025 and concludes July 31, 2026, focuses on refining detection software, validating user acceptability, and...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $235,500 Project Grant on June 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of California, Irvine to develop, refine, field test, and deploy an artificial intelligence-based chatbot designed to enhance engagement in mobile peer-to-peer support groups for smoking cessation and tobacco addiction treatment. The chatbot, built on a state-of-the-art large language...